We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Show more
Submitted New Drug Application (NDA) for taletrectinib to the U.S. Food and Drug Administration (FDA) in October for the treatment of patients with advanced ROS1-positive (ROS1+) non-small cell...
Global leader with proven financial, operational, and commercial expertise joins Nuvation Bio as the company prepares to transition into a commercial-stage organization Nuvation Bio Inc. (NYSE:...
Tumors shrank in 89% of taletrectinib-treated patients with advanced ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC) who were tyrosine kinase inhibitor (TKI)-naïve and 56% of those who...
Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.755 | 32.9694323144 | 2.29 | 3.08 | 2.18 | 2239068 | 2.63090622 | CS |
4 | 0.775 | 34.140969163 | 2.27 | 3.08 | 2.18 | 1634655 | 2.44628228 | CS |
12 | 0.315 | 11.5384615385 | 2.73 | 3.3986 | 2 | 1607974 | 2.61395239 | CS |
26 | -0.205 | -6.30769230769 | 3.25 | 3.97 | 2 | 1622342 | 2.87528876 | CS |
52 | 1.785 | 141.666666667 | 1.26 | 4.1598 | 1.21 | 1377449 | 2.67610818 | CS |
156 | -5.695 | -65.1601830664 | 8.74 | 10.45 | 0.95 | 1035087 | 3.14776327 | CS |
260 | -6.955 | -69.55 | 10 | 15.23 | 0.95 | 984854 | 4.38737982 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions